zydus going to 930 a good chart pattern forming and making lower low also broke recent support
tgt -930
ZYDUSLIFE trade ideas
ZYDU LIFE Long Term AnalysisZydu LIFE currently at very good support, There is good volume around that levels. and crossed VAH. also there is a trendline. it might bounce from that level.
ZydusLife | Looking bullish ⭕️ Swing Trading opportunity: Price Action Analysis Alert !!!⭕️
💡FNO Stocks Trading📉📈📊
✅Check out my TradingView profile to see how we analyze charts and execute trades.
✅We can't conduct a thorough analysis in such a short span of time. We need to review it, post our findings, and then take action.
🙋♀️🙋♂️If you have any questions about this stock, feel free to reach out to me.
📍📌Thank you for exploring our idea! We hope you found it valuable.
🙏FLLOW for more !
👍LIKE if useful !
✍️COMMENT Below your view !
Stock in Consolidation: Zydus Lifesciences Ltd.ZYDUSLIFE has been consolidating for the past couple of weeks.
RSI of 43 shows weakness in the price momentum.
It has strong support around 1108.
Resistance levels are around 1213, 1300.
20EMA (Black Line) just crossed below the 50 EMA (Orange Line) indicating the weakness.
However, if the support of 1108 is firmly held, we can expect some price momentum in the upside toward 1156 levels.
We need decisive strength in volume to gain price momentum.
ZYDUSLIFE - A NEGATIVE RSI DIVERGNCE LETS SEE HOW IT EVOLVESZydus Lifesciences Ltd. Negative RSI Divergence on weekly chart
1. A picture Perfect negative RSI divergence on weekly chart
2. Price forming higher highs where as RSI is sliding downwards
3. Super Trend Turned sell on weekly chart
4. Fall in price followed by huge volume candles
5. RSI on daily near 40
Lets See How it Evolves.
Disclaimer: NOT A BUY / SELL RECOMMENDATION I am not an expert I just share interesting charts here for educational purpose and not to be taken as buy/sell recommendation. Please seek expert opinion before investing and trading as trading/ investing in market is subject to market risks. I do not hold any position in the stock as on date but I may look to have some with my own Risk Reward matrix
Zydus Lifesciences Ltd - Analysis
Zydus Lifesciences Ltd., an Indian pharmaceutical giant, has demonstrated a robust performance in recent financial periods, marked by significant growth in revenues and profits. In FY2024, Zydus reported a remarkable 95.25% year-on-year increase in profit after tax (PAT), reaching ₹3,836.5 crore. This surge was driven by strong sales across key markets like India, the U.S., and Europe, with consolidated revenues rising by 13.39% to ₹19,547.4 crore. The company's EBITDA also saw a substantial rise of 40%, reaching ₹5,384.3 crore.
The company’s domestic business, which includes formulations and consumer wellness products, contributed to 40% of total revenues in Q4 FY24, with notable growth in branded formulations and personal care segments. The U.S. market remained a significant revenue driver, contributing 47% to the consolidated revenues, thanks to new product launches and approvals for several ANDAs.
In terms of financial health, Zydus maintains a solid market position with a market capitalization of approximately ₹125,568 crore, a PE ratio of 32, and a return on equity (ROE) of 21%. The promoter holding remains strong at 74.98%, reflecting confidence in the company's future prospects.
Overall, Zydus Lifesciences continues to showcase resilience and growth in a competitive pharmaceutical landscape, supported by its diversified product portfolio and strategic market expansions.
Disclaimer: I am not a financial advisor, and this information should not be taken as financial advice. Always conduct your own research or consult with a professional before making investment decisions.
Bearish Breakdown: Zydus Life Below 1100, Potential Drop to 940Details:
Asset: Zydus Lifesciences Limited (ZYDUSLIFE)
Breakout Level: Below 1100
Potential Target: 940-900
Stop Loss: Above 1100 or as per risk tolerance
Timeframe: Short to medium-term
Rationale: Zydus Lifesciences Limited (ZYDUSLIFE) is facing a potential bearish move due to a channel breakdown and negative news regarding a warning letter from the USFDA for its Jarod facility. If the stock breaks below the 1100 level, it could see a further decline towards the 940-900 range.
Market Analysis:
Technical Breakdown: The breakdown below 1100 signals a bearish trend, with the possibility of further downside pressure.
Fundamental Impact: The warning letter from the USFDA adds to the negative sentiment, potentially exacerbating the downward move.
Price Target:
The targets for ZYDUSLIFE are set at 940 and 900, based on the expected move following the channel breakdown and the impact of the negative news.
Risk Management:
Implementing a stop loss strategy above 1100 is essential to manage risk in case of any unexpected reversals or news-driven rallies.
Timeframe:
The projected move towards 940-900 is based on a short to medium-term outlook, but actual timing may vary depending on market reactions to the news and technical factors.
Risk-Reward Ratio: Consider individual risk tolerance and adjust position size accordingly to maintain a favorable risk-reward ratio.
Source
As with any investment opportunity, conduct thorough analysis and consider factors such as market trends, company fundamentals, and risk management strategies before making trading decisions.
ZYDUS LIFE NEAR THE RESSITANCE CANGIVE BREAKOUT Zydus Lifesciences Ltd try to pass 50 days EMA.
A give breakout.
Result is good
Investment Idea for Long term InvestorTrade idea for Long term Investors
High Reward Trade for High Risk Investors
Success rate 80% - 90%
"Realize Full Potential of a Stock by having Patience"
"Stock Market is more about What can happen rather-than what will Happen"
In Markets there is no 100% Guarantee but one can invest in High Probability Stocks
ALWAYS KEEP IN MIND
Rule 1 : Respect Target & Stop-loss.
Rule 2 : Hold the Trade until the Rule 1 is not met.
Rule 3 : SL on Day Close Basis
Rule 4 : Never do averaging if trade moves against your direction
One can add more quantity when the stock achieves target 1
ZYDUSLIFEThe chart is self-explanatory and shared for educational purposes. The ZYDUSLIFE stock is trading above the 50, 150, and 200 moving averages. The resistance level has been broken with a small correction and is now sustaining above it. This resistance could now act as support. Considering the current aspect, the stock could move further upward.
ZYDUS LIFESCIENCES 15 MINSThe chart shows a bullish trend, with the price bouncing off the support level of 1,150 INR
The candlestick pattern shows a bullish engulfing pattern, where the green candle completely engulfs the previous red candle, indicating a strong buying pressure.
if the price breaks below the support level of 1,150 INR, it could be considered a sell signal.
Alternatively, if the price reaches a strong resistance level of 1165 a short trade can be entered if a strong bearish candle pattern appears.
........
Please note that this analysis is based on a limited time frame and should not be considered as financial advice. It's always recommended to conduct thorough research and consider multiple time frames before making any investment decisions.
Zydus Lifesciences Ltd - Long Setup, Move is ON...#ZYDUSLIFE trading above Resistance of 892
Next Resistance is at 1128
Support is at 673
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
Zydus Lifesciences, cmp 7141. Cup and Handle breakout in weekly chart
2. Target of 1010, 41% - Timeperiod less than a year.
3. Do your research.
ZyduslifeThis stock up move as per the below prediction
1.21 Ema above 50 Ema
2.50 Ema above 200 Ema
3.Price above 21 EMA
4.21 Ema retrace
5.Stock in upmove
5.ROCE >15
6.Debt to equity<1
This is for the educational purposes
Zydus life science cup and handle PatternIt is trading at 682. It has crossed it neckline of 680. Volume is really good. Daily, weekly and monthly RSI above 60 .
If its manage to give weekly closed above 680 then we can consider this as cup and handle breakout
1st target :770
2nd target:1000
30 week moving average as stop loss
This is for educational purpose. Not a buy recommendation
Fundamentally strong stock BO in Daily TFCompany results are good and fundamentally strong.
Breakout of Cup and holder pattern in daily frame,
Long term - Very positive.
Potential upside of 13% in short term and 27% in Med-Long term from the current levels.
Fib Retracement level of 1.618 broken and stock is trading at ATH levels.
BO of Cup & Holder Pattern and Fib Ret 1.618 LevelCompany results are good and fundamentally strong.
Breakout of Cup and holder pattern in daily frame,
Long term - Very positive.
Potential upside of 13% in short term and 27% in Med-Long term from the current levels.
Fib Retracement level of 1.618 broken and stock is trading at ATH levels.
ZYDUSLIFE BREAKING OUT FROM 2-MONTH CONSOLIDATIONZYDUSLIFE after an 82% rally, from Oct 2023 low to April 2024 high, without any significant pullback (greater than 8%) has been consolidating for the last 2 months that has now turned into a bullish Head & Shoulder pattern. The stock is attempting a breakout from this bullish pattern on about 2 times average volume. Momentum oscillator, RSI, too is indicating bullishness as it is entering above 60 zone. Technical structure and momentum on the monthly and weekly charts are strongly bullish. On the fundamentals side over the last 6 quarters (till Dec 2023) EPS has been recording significant growth. As the results for Mar 2024 Qtr are awaited shortly it is good to wait for the results before taking a call.
Only personal analysis. No recommendation. Please consult your financial advisor before taking any decision.
Zydus life unmoved possiblitiesThis stock up move as per the below prediction
1.21 Ema above 50 Ema
2.50 Ema above 200 Ema
3.Price above 21 EMA
4.21 Ema retrace
5.Stock in unmoved
5.ROCE >15
6.Debt to equity<1
This is for the educational purposes
